Fifth Third Bancorp
BMY.RT

Fifth Third Bancorp’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Fifth Third Bancorp’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-283,453
Closed -$196K – 2539
2020
Q4 		$196K Sell
283,453
-8,700
-3% -$18.5K ﹤0.01% 941
2020
Q3 		$657K Sell
292,153
-12,019
-4% -$34.3K ﹤0.01% 590
2020
Q2 		$1.09M Buy
304,172
+12,701
+4% +$45.8K 0.01% 497
2020
Q1 		$1.11M Sell
291,471
-128,019
-31% -$422K 0.01% 461
2019
Q4 		$1.26M Buy
+419,490
New +$1.09M 0.01% 491

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Fifth Third Bancorp's BMY.RT Position: Q1 2021 in Review

Fifth Third Bancorp sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 283,453 shares — an estimated $196K sold.

Fifth Third Bancorp first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $1.26M in Q4 2019. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Fifth Third Bancorp reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Fifth Third Bancorp sold 283,453 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $196K.
  • Fifth Third Bancorp first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Fifth Third Bancorp's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $1.26M in Q4 2019.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Fifth Third Bancorp's 13F filing for Q1 2021, filed 7 May 2021.